These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15608391)

  • 21. Microarray reveals differences in both tumors and vascular specific gene expression in de novo CD5+ and CD5- diffuse large B-cell lymphomas.
    Kobayashi T; Yamaguchi M; Kim S; Morikawa J; Ogawa S; Ueno S; Suh E; Dougherty E; Shmulevich I; Shiku H; Zhang W
    Cancer Res; 2003 Jan; 63(1):60-6. PubMed ID: 12517778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A subset of CD5- diffuse large B-cell lymphomas expresses nuclear cyclin D1 with aberrations at the CCND1 locus.
    Ehinger M; Linderoth J; Christensson B; Sander B; Cavallin-Ståhl E
    Am J Clin Pathol; 2008 Apr; 129(4):630-8. PubMed ID: 18343791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytogenetic features of de novo CD5-positive diffuse large B-cell lymphoma: chromosome aberrations affecting 8p21 and 11q13 constitute major subgroups with different overall survival.
    Yoshioka T; Miura I; Kume M; Takahashi N; Okamoto M; Ichinohasama R; Yoshino T; Yamaguchi M; Hirokawa M; Sawada K; Nakamura S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):149-57. PubMed ID: 15543600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries.
    Xu-Monette ZY; Tu M; Jabbar KJ; Cao X; Tzankov A; Visco C; Nagarajan L; Cai Q; Montes-Moreno S; An Y; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Miranda RN; Medeiros LJ; Young KH
    Oncotarget; 2015 Mar; 6(8):5615-33. PubMed ID: 25760242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
    Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
    Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [De novo CD5-positive diffuse large B-cell lymphoma with leukemic dissemination diagnosed by immunohistochemical examinations of bone marrow clot sections].
    Yoshida K; Kayano H; Akiba M; Kishimoto K; Takahashi N; Sugahara Y; Kawai N; Matsuda A; Hirashima K; Suzuki T; Bessho M
    Rinsho Ketsueki; 2002 Oct; 43(10):943-8. PubMed ID: 12462031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
    Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
    Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathway analysis of informative genes from microarray data reveals that metabolism and signal transduction genes distinguish different subtypes of lymphomas.
    Mircean C; Tabus I; Kobayashi T; Yamaguchi M; Shiku H; Shmulevich I; Zhang W
    Int J Oncol; 2004 Mar; 24(3):497-504. PubMed ID: 14767533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
    Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
    Ok CY; Xu-Monette ZY; Tzankov A; O'Malley DP; Montes-Moreno S; Visco C; Møller MB; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Han van Krieken J; Ponzoni M; Farnen JP; Piris MA; Winter JN; Medeiros LJ; Young KH
    Cancer; 2014 Jun; 120(12):1818-29. PubMed ID: 24648050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A rare CD5-positive subgroup of diffuse large B-cell lymphoma - clinical, morphological and immunophenotypic features in Polish patients.
    Woźnialis N; Gierej B; Popławska L; Ziarkiewicz M; Kulczycka E; Ziarkiewicz-Wróblewska B
    Pol J Pathol; 2016; 67(3):235-243. PubMed ID: 28155972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo CD5-positive primary cardiac diffuse large B-cell lymphoma diagnosed by pleural fluid cytology.
    Cioc AM; Jessurun J; Vercellotti GM; Pambuccian SE
    Diagn Cytopathol; 2014 Mar; 42(3):259-67. PubMed ID: 23007953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
    Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
    Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
    Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
    Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis in CD5-positive Diffuse Large B Cell Lymphoma: A Morphometric Analysis.
    Woźnialis N; Gierej B; Popławska L; Ziarkiewicz M; Wolińska E; Kulczycka E; Ziarkiewicz-Wróblewska B
    Adv Clin Exp Med; 2016; 25(6):1149-1155. PubMed ID: 28028967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiling of diffuse large B-Cell lymphomas supervised by CD5 expression.
    Miyazaki K; Yamaguchi M; Imai H; Kobayashi K; Tamaru S; Kobayashi T; Shiku H; Katayama N
    Int J Hematol; 2015 Aug; 102(2):188-94. PubMed ID: 26009281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma.
    Suzuki Y; Sakakibara A; Shimada K; Shimada S; Ishikawa E; Nakamura S; Kato S; Takahara T; Asano N; Satou A; Kohno K
    Pathol Int; 2019 Jan; 69(1):13-20. PubMed ID: 30601579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma of ocular adnexal origin: usefulness of fluorescence in situ hybridization for distinction between mantle cell lymphoma and MALT lymphoma.
    Tasaki K; Shichishima A; Furuta M; Yoshida S; Nakamura N; Abe M
    Pathol Int; 2007 Feb; 57(2):101-7. PubMed ID: 17300675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of D-type cyclins in mantle cell and diffuse large B-cell lymphomas.
    Zlamalikova L; Moulis M; Salek D; Jarkovsky J; Smarda J; Smardova J
    Oncol Rep; 2016 May; 35(5):2673-80. PubMed ID: 26985765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.